An epidemiologist’s perspective
There is no shortage of stuff in the media and it is hard to make sense of it all. Hope this helps!
Latest from the Blog
Pfizer vs AstraZeneca vaccine: first comparative data
The number one question that people in the UK when chatting to each other in the past few weeks is “Which vaccine did you have?”! Yesterday (22nd February) the Scottish Government published preliminary data from their first 1.1 million people who had been enrolled in the national vaccine roll out programme. This programme, like the rest of […]
New Israeli data show good protection after one dose of Pfizer vaccine
New data published yesterday in the Lancet appeared to show that there is very good protection from becoming infected with Covid-19 two weeks after one dose of the Pfizer vaccine. In this post I describe the results, what are their limitations and what they mean. I also relate the results to similar data from AstraZeneca. What did […]
Why our T cells could take out anxiety about whether the vaccines are effective: new variants or not!
As vaccine rollout grows apace, the media are full of concerns that vaccines may not protect everyone, and may prove much less useful against new variants of the Covid-19 virus. The EU announced this afternoon support for researching new vaccines. In this post, however, I want to give a fuller introduction to the less well-known aspect […]
Get new content delivered directly to your inbox
